HealthQuill pancreatic cancer
Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival for its investigational therapy to treat liver cancer.
Uncategorized

Bayer and Kumquat Biosciences ink $1.3 billion deal to develop cancer inhibitor

HQ Team August 13, 2025: Bayer and Kumquat Biosciences, a clinical-stage biotech, announced an exclusive global license and collaboration agreement worth $1.3 billion.

Read More
Patients with cancer are markedly insulin-resistant, similar to people with type 2 diabetes, and it can lead to cancer spreading faster, according to a study by researchers at the University of Copenhagen.
Drugs Health

New pancreatic cancer vaccine shows promise in preventing recurrence in trial-1

HQ Team August 12, 2025: A new study published in the journal Nature Medicine has shown promising results for an experimental vaccine, ELI-002.

Read More
IntraBio Inc, a biotechnology company focused on rare and neurodegenerative diseases, got the US regulator’s nod for a drug to treat a certain type of Niemann-Pick disease in adults and pediatric patients weighing about 15 kilograms.
Health

Primary care clinics can help detect 10% of cancers caused by genes

HQ Team March 10, 2025: Patient screening in primary care settings can detect up to 10% of cancers caused by genes. Easily available.

Read More